Skip to content
Subscribe

Browse the archive

Category: Weekly IP Digest

Weekly IP Digest

Weekly Indian IP Law Digest: July 19 to July 25

Stay updated with the latest Indian Intellectual Property developments from July 19 to July 25, 2026. This week’s digest covers critical rulings, including the Delhi High Court’s landmark dismissal of the interim injunction in ANI Media v. OpenAI, emphasizing the research exception in AI training. We also review significant decisions in trademark law regarding the 'OFFER' mark, copyright groundless threats involving TVS Motor, and dynamic injunctions against piracy. Additionally, catch up on GI tag updates from Haryana and Jharkhand and significant international developments involving the Digital Services Act and Anthropic.

11 min read
Weekly IP Digest

Weekly Indian IP Law Digest: July 12-18, 2026

This week's IP digest covers critical developments in Indian trademark and copyright law. Highlights include the Delhi High Court's stance on amending plaints post-registration, the interplay between competing registered trademarks, and the latest GI tag updates from Gujarat and Himachal Pradesh. We also analyze international developments, including the Apple-OpenAI trade secret dispute and important US patent rulings. Stay informed on the latest jurisprudence from the Delhi and Bombay High Courts, alongside significant updates on GI registrations and global intellectual property trends impacting the Indian market throughout the month of July.

13 min read
Weekly IP Digest

Weekly Indian IP Law Digest: July 5–11, 2026

The second week of July 2026 saw significant activity across Indian courts. Key rulings include the Delhi High Court's rejection of bioavailability as a basis for therapeutic efficacy in patent law and the Bombay High Court's crackdown on unsupported 'common general knowledge' claims by the Patent Office. We also cover the latest developments in trademark disputes, including the boAt v. BOULT matter and new injunctions against AI-driven copyright scraping. Stay updated on these essential legal developments and international IP cases, including the latest in the AstraZeneca and OpenAI litigations.

21 min read